<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04851951</url>
  </required_header>
  <id_info>
    <org_study_id>PRP-shoulder</org_study_id>
    <nct_id>NCT04851951</nct_id>
  </id_info>
  <brief_title>Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis</brief_title>
  <official_title>Clinical Results Of Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis, Our Experience At Short-Term Follow Up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was conducted a prospective study with a series of 50 patients treated with PRP one-shot&#xD;
      injection in patient affected by Supraspinatus Tendinosis. One independent observer performed&#xD;
      clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection),&#xD;
      T2 (three months after the last injection) and T3 (six months after the last injection).&#xD;
&#xD;
      Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue&#xD;
      Scale (VAS) were administered at each evaluation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">April 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Visual Analogic Scale</measure>
    <time_frame>Day 0; Month 1; Month 3; Month 6 (after the injection)</time_frame>
    <description>The shoulder pain was quantified using the Visual Analogic Scale ranging from 0 (no pain) to 10 (worst imaginable pain).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Supraspinatus Tendinitis</condition>
  <arm_group>
    <arm_group_label>patients treated by one-shot PRP injection</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>one-shot PRP injection</intervention_name>
    <description>A single injection of PRP (7% concentrate) ml 4 was made in the Supraspinatus tendon and in the Subacromial space under ultrasound guidance.</description>
    <arm_group_label>patients treated by one-shot PRP injection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Fifty (50) patients referring to the Orthopaedic and Trauma Unit of the local University&#xD;
        Hospital between January 2018 and July 2020 with Supraspinatus tendinosis were&#xD;
        prospectively recruited.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years old;&#xD;
&#xD;
          -  Supraspinatus tendinosis detected by MRI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Supraspinatus rupture;&#xD;
&#xD;
          -  Previous shoulder surgery;&#xD;
&#xD;
          -  Rotator cuff tears secondary to fracture;&#xD;
&#xD;
          -  Hemoglobin &lt;7 g/dL or Platelets &lt; 30,000 microL;&#xD;
&#xD;
          -  Active infection;&#xD;
&#xD;
          -  Pregnant patients;&#xD;
&#xD;
          -  Patients with hematologic and oncologic diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AOUC Policlinico di Bari - UOC Ortopedia e Traumatologia</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 15, 2021</study_first_submitted>
  <study_first_submitted_qc>April 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Supraspinatus tendinosis; PRP; Shoulder;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

